MedicaidPrior AuthMedium impact
KMAP BULLETIN: Preferred Drug List Update March 2025
Kansas Medicaid (KanCare)·KS · Dermatology, Gastroenterology, Rheumatology +2 more·Pharmacy
Effective date
Mar 1, 2025
We identified it
Jun 21, 2026
Summary
Kansas Medicaid (KMAP) is changing preferred drug status for multiple medications effective March 1, 2025. Ten medications including Zoryve, Vtama, and Tremfya will require prior authorization, while five medications including Catapres and Paxlovid will become preferred with no prior auth needed.
Action Required
Before March 1, 2025: Update billing system and staff workflows to require prior authorization for 10 newly non-preferred medications (Zoryve, Vtama, Ebglyss, Nemluvio, Bimzelx, Cimzia, Tremfya, Voquezna, Opsynvi, Nexiclon XR) for Kansas Medicaid patients. Remove prior auth requirements for newly preferred medications (Catapres-TTS, Catapres, Tenex, Aldomet, Paxlovid). Train clinical staff on new requirements and update encounter forms. Claims for non-preferred drugs without prior authorization will be denied.